Report Company Directory

CHINA RESOURCES MIXC LIFEST SVS LTD

China Resources Mixc Lifestyle Services (Red Chip)

• China Property Management: 2024 results wrap-up: Overall stable business development with a higher dividend payout ratio. by UOB
• Regional Morning Meeting Notes: Thursday, March 27, 2025 by UOB
• Greater China Daily: Thursday, March 27, 2025 by UOB
• China Resources Mixc Lifestyle Services (1209 HK): 2024: Results beat with 100% payout ratio; pursuing high-quality growth. by UOB
• China Property And China Property Management Strategy: Property market marginally cools down before CNY; 2024 earnings preview on COLI/CR Land/COPH. by UOB
• Regional Morning Meeting Notes: Friday, January 17, 2025 by UOB
• China Property Management: 2024 preview of CR Mixc/PPS/CGS. by UOB
• Regional Morning Notes - Wednesday, March 27, 2024 by UOB
• Regional Morning Meeting Notes: Tuesday, December 03, 2024 by UOB
• Greater China Daily: Tuesday, December 3, 2024 by UOB

China Resources Pharmaceutical Group Ltd.

• A double requalification allows CHINA RESOURCES PHARMACEUTICAL GROUP to improve to Slightly Positive by TheScreener
• Morningstar | CR Pharma's Full-Year Results in Line, but Less Impressive Than 1H; Debt Levels Rise. See Updated Analyst Note from 22 Mar 2019 by Morningstar
• CR Pharma's Full-Year Results in Line, but Less Impressive Than 1H; Debt Levels Rise by Morningstar
• CR Pharma Is a Well-Branded Pharmaceutical Conglomerate in China by Morningstar
• Morningstar | CR Pharma's Full-Year Results in Line, but Less Impressive Than 1H; Debt Levels Rise by Morningstar
• Morningstar | China to audit 77 drugmakers, government likely to speed up pricing reform by Morningstar
• China to audit 77 drugmakers, government likely to speed up pricing reform by Morningstar
• China Resources Pharmaceutical Group Limited: 1 director maiden bought by SmartInsider
• Morningstar | Fudan Zhangjiang Applies for Listing in China; Chinese Healthcare Stocks Rally by Morningstar
• Fudan Zhangjiang Applies for Listing in China; Chinese Healthcare Stocks Rally by Morningstar

China Resources Power Holdings Co. Ltd.

• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research

China Resources Sanjiu Medical & Pharmaceutical Co. Ltd. Class A

• 快评: 华润三九 "Q125收入不及预期" (买入) 朱 by UBS AG
• First Read: Sanjiu Medical & Ph "Q125 revenue missed" (Buy) Zhu by UBS AG
• 快评: 华润三九 "2024年业绩保持稳健；2025年收入/利润指引双位数增长" (买入) 朱 by UBS AG
• First Read: Sanjiu Medical & Ph "Solid 2024 results; guided for..." by UBS AG
• 快评: 华润三九 "业绩快报符合预期" (买入) 朱 by UBS AG
• First Read: Sanjiu Medical & Ph "FY24 pre-results in line" (Buy) Zhu by UBS AG
• 中国中药行业月度追踪 "25年1月中药材价格同比下降5%，价格下行利好中成药公司毛利率" 朱 by UBS AG
• China TCM Monthly Tracker "TCM raw material prices down 5% YoY in Jan..." by UBS AG
• China Healthcare "Outlook 2025: Structural opportunities amid uncertainty" Chen by UBS AG
• 中国中药行业月度追踪 "H224中药材价格下行；2024年中药材价格指数同比仅增长1%" 朱 by UBS AG